Drink from the fountain of youth with Melrose Nicotinamide Riboside (NR) Liposomal combines that latest in nutrient delivery technology, PlexoZome ® together with bioavailable Nicotinamide Riboside to support energy.
Melrose Nicotinamide Riboside Liposomal combines that latest in nutrient delivery technology, PlexoZome® together with bioavailable Nicotinamide Riboside to support energy.
Nicotinamide Riboside (NR) is a precursor for nicotinamide adenine dinucleotide (NAD+) a cofactor that is critical to cell metabolism. As we age, the demand on the NAD+ pool exceeds its availability, and NR helps to restore the depleted NAD+ levels.
Reap The Benefits Of Every Drop
Unlike traditional forms of vitamins, liposomal technology uses a unique delivery system that allows enhanced absorption and effectiveness.
Our innovative Nicotinamide Riboside Liposomal Liquid is designed to support cellular energy production.
Each dose is packed with nutrients to support energy and is enclosed in a liposomal shell for enhanced absorption and bioavailability.
Nicotinamide Riboside (NR) a unique form of vitamin B3 that serves as a cofactor for NAD+ and helps support energy and general health.
Suitable for those with sensitive stomachs
Easy-to-take, liquid formula makes it simple to incorporate essential vitamins into your daily skin routine to maintain a radiant glow.
Ingredients:
Each 1.8g (3 pumps) contains:
Nicotinamide riboside chloride 100mg equiv. ribose 45.9mg
Usage Directions:
Dispense 1.8mL (3 pumps) under tongue once a day. Hold under tongue for 5 seconds before swallowing. Not to be taken by children under 18 years. Do not use if tamper evident seal is broken or missing.
Warnings:
Always read the label and follow the directions for use. Adults only. If symptoms persist, talk to your health professional. Contains ethanol 12% w/w. Vitamins can only be of assistance if dietary intake is inadequate. Contains soya bean products. Not recommended for use during pregnancy or lactation.
Raspberry sorbet flavour
Reviews
There are no reviews yet.